Secondary Progress Multiple Sclerosis
2 clinical trials · Condition
◉ Watch Secondary Progress Multiple Sclerosis
| Record | Firm | Date |
|---|---|---|
| A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis (NCT02057159) | Immune Response BioPharma, Inc. | 2020-03-09 |
Track Secondary Progress Multiple Sclerosis automatically
Every clearance here is in the API, with alerts when new ones post.